Table 4. Bayesian network meta-analysis outcomes based on a consistency model using SAVR as a baseline comparator.

Variable	MiAVR	MiSuAVR	SuAVR	Test for inconsistency
Mortality	0.73 (0.46–1.13), P=0.16	0.64 (0.3–1.38), P=0.25	1.49 (0.28–1.62), P=0.37	P=0.41
Stroke	0.78 (0.49–1.25), P=0.30	1.05 (0.51–2.18), P=0.89	1.4 (0.52–3.86), P=0.50	P=0.50
Bleeding	1.17 (0.79–1.77), P=0.42	1.22 (0.67–2.23), P=0.52	0.59 (0.22–1.57), P=0.29	P=0.18
AKI	0.98 (0.42–2.27), P=0.96	1.01 (0.36–2.86), P=0.98	0.82 (0.22–2.97), P=0.76	P=0.45
POAF	0.82 (0.58–1.15), P=0.25	0.61 (0.32–1.15), P=0.13	0.33 (0.14–0.79), P=0.013	–
PPM	1.05 (0.63–1.75), P=0.86	2.27 (1.25–4.14), P=0.008	0.70 (0.12–4.06), P=0.69	–
Infection	0.62 (0.29–1.34), P=0.22	0.56 (0.18–1.8), P=0.33	0.63 (0.13–3.00), P=0.56	P=0.97
CPB (min)	6.7 (−2.0–15.5), P=0.13	−24.2 (−35.1–−13.4), P<0.001	−27.6 (−41.8–−13.3), P<0.001	P=0.67
X-clamp (min)	5.2 (−1.1–11.5), P=0.11	−23.9 (−31.8–−16.0), P<0.001	−26.1 (−36.1–−16.1), P<0.001	P=0.96
Vent (hrs)	−0.91 (−2.06–0.23), P=0.12	−3.43 (−5.47–−1.38), P=0.001	−2.49 (−5.14–0.17), P=0.07	–
ICU LOS (days)	−0.10 (−0.45–0.26), P=0.60	−0.27 (−0.80–0.27), P=0.33	−0.35 (−1.30–0.59), P=0.46	P=0.38
Hospital LOS (days)	−1.53 (−2.85–−0.21), P=0.02	−2.79 (−4.81–−0.78), P=0.007	−3.37 (−5.81–−0.94), P=0.007	P=0.04

Results are shown as odds ratio (95% confidence interval) for dichotomous variables and mean difference (95% CI) for continuous variables. AKI, acute kidney injury; X-clamp, cross-clamp time; CPB, cardiopulmonary bypass time; ICU, intensive care unit; LOS, length of stay; MiAVR, minimally invasive aortic valve replacement; MiSuAVR, sutureless aortic valve replacement via minimally invasive procedure; POAF, postoperative atrial fibrillation; PPM, permanent pacemaker; SuAVR, sutureless aortic valve replacement via full sternotomy; Vent, ventilation time.